Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

de Botton S, Sanz MA, Chevret S, Dombret H, Martin G, Thomas X, Mediavilla JD, Recher C, Ades L, Quesnel B, Brault P, Fey M, Wandt H, Machover D, Guerci A, Maloisel F, Stoppa AM, Rayon C, Ribera JM, Chomienne C, Degos L, Fenaux P; European APL Group; PETHEMA Group.

Leukemia. 2006 Jan;20(1):35-41.

PMID:
16307026
[PubMed - indexed for MEDLINE]
2.

Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.

De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Condé E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P.

Blood. 1998 Oct 15;92(8):2712-8.

PMID:
9763554
[PubMed - indexed for MEDLINE]
Free Article
3.

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.

Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P.

Leukemia. 2000 Jun;14(6):1006-13.

PMID:
10865965
[PubMed - indexed for MEDLINE]
4.
5.

Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.

Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N, Sanz M, Dombret H, Fenaux P, Adès L.

J Clin Oncol. 2009 Jun 1;27(16):2668-76. doi: 10.1200/JCO.2008.18.4119. Epub 2009 May 4.

PMID:
19414681
[PubMed - indexed for MEDLINE]
Free Article
6.

Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapy.

Gupta V, Yib QL, Brandwein J, Chun K, Lipton JH, Messner H, Schuh AC, Wells RA, Minden MD, Kamel-Reidc S.

Leuk Lymphoma. 2004 Mar;45(3):469-80.

PMID:
15160908
[PubMed - indexed for MEDLINE]
7.

Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy.

Thomas X, Anglaret B, Thiebaut A, Belhabri A, Treille-Ritouet D, Fiere D, Archimbaud E.

Ann Hematol. 1997 Nov-Dec;75(5-6):195-200.

PMID:
9433375
[PubMed - indexed for MEDLINE]
8.

Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.

de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M, de La Serna J, Philippe N, Baruchel A, Leverger G, Robert A, San Miguel J, Conde E, Sotto JJ, Bordessoule D, Fegueux N, Fey M, Parry A, Chomienne C, Degos L, Fenaux P.

J Clin Oncol. 2004 Apr 15;22(8):1404-12.

PMID:
15084614
[PubMed - indexed for MEDLINE]
Free Article
9.

CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy.

Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, Boccuni P, Di Noto R, Pane F, Annunziata M, Schiavone EM, De Simone M, Guglielmi C, Del Vecchio L, Lo Coco F.

J Clin Oncol. 2000 Mar;18(6):1295-300.

PMID:
10715300
[PubMed - indexed for MEDLINE]
10.

Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.

Ortega JJ, Madero L, Martín G, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA; PETHEMA Group.

J Clin Oncol. 2005 Oct 20;23(30):7632-40.

PMID:
16234524
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.

Burry LD, Seki JT.

Ann Pharmacother. 2002 Dec;36(12):1900-6. Review.

PMID:
12452754
[PubMed - indexed for MEDLINE]
13.

[Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].

Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.

Zhongguo Dang Dai Er Ke Za Zhi. 2007 Feb;9(1):28-33. Chinese.

PMID:
17306073
[PubMed - indexed for MEDLINE]
14.

Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto.

Specchia G, Lo Coco F, Vignetti M, Avvisati G, Fazi P, Albano F, Di Raimondo F, Martino B, Ferrara F, Selleri C, Liso V, Mandelli F.

J Clin Oncol. 2001 Oct 15;19(20):4023-8.

PMID:
11600603
[PubMed - indexed for MEDLINE]
15.

Long-term survey of outcome in acute promyelocytic leukemia.

Hu J, Shen Z, Sun H, Wu W, Li X, Sun G, Wang Z.

Chin Med J (Engl). 2000 Feb;113(2):107-10.

PMID:
11775530
[PubMed - indexed for MEDLINE]
Free Article
16.

Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group.

Bally C, Fadlallah J, Leverger G, Bertrand Y, Robert A, Baruchel A, Guerci A, Recher C, Raffoux E, Thomas X, Leblanc T, Idres N, Cassinat B, Vey N, Chomienne C, Dombret H, Sanz M, Fenaux P, Adès L.

J Clin Oncol. 2012 May 10;30(14):1641-6. doi: 10.1200/JCO.2011.38.4560. Epub 2012 Apr 2.

PMID:
22473162
[PubMed - indexed for MEDLINE]
Free Article
17.

Acute promyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone.

Advani SH, Nair R, Bapna A, Gladstone B, Kadam P, Saikia TK, Parekh PM, Gopal R, Nair CN.

Am J Hematol. 1999 Feb;60(2):87-93.

PMID:
9929098
[PubMed - indexed for MEDLINE]
18.

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.

Esteve J, Escoda L, Martín G, Rubio V, Díaz-Mediavilla J, González M, Rivas C, Alvarez C, González San Miguel JD, Brunet S, Tomás JF, Tormo M, Sayas MJ, Sánchez Godoy P, Colomer D, Bolufer P, Sanz MA; Spanish Cooperative Group PETHEMA.

Leukemia. 2007 Mar;21(3):446-52. Epub 2007 Jan 4.

PMID:
17205057
[PubMed - indexed for MEDLINE]
19.

Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment.

Chou WC, Tang JL, Yao M, Liang YJ, Lee FY, Lin MT, Wang CH, Shen MC, Chen YC, Tien HF.

Leukemia. 1997 Jul;11(7):921-8.

PMID:
9204969
[PubMed - indexed for MEDLINE]
20.

Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).

Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R.

Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S65-71.

PMID:
11587370
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk